Latest News
Wondering if the leading Russell 2000 ETF deserves a spot in your portfolio? Be careful -- you'll need inhuman market timing to beat the broader market.
Via The Motley Fool · May 1, 2025
Via The Motley Fool · May 1, 2025
Industrial products distributor Applied Industrial (NYSE:AIT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.8% year on year to $1.17 billion. Its GAAP profit of $2.57 per share was 6.6% above analysts’ consensus estimates.
Via StockStory · May 1, 2025
FedEx Corp (NYSE:FDX) as a Dividend Stock
Via Chartmill · May 1, 2025
Via The Motley Fool · May 1, 2025
Consumer packaging solutions provider Graphic Packaging Holding (NYSE:GPK) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 6.2% year on year to $2.12 billion. On the other hand, the company’s full-year revenue guidance of $8.35 billion at the midpoint came in 3.7% below analysts’ estimates. Its non-GAAP profit of $0.51 per share was 11.5% below analysts’ consensus estimates.
Via StockStory · May 1, 2025
Via The Motley Fool · May 1, 2025
Via The Motley Fool · May 1, 2025
Snack food company Utz Brands (NYSE:UTZ) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.6% year on year to $352.1 million. Its non-GAAP profit of $0.16 per share was in line with analysts’ consensus estimates.
Via StockStory · May 1, 2025
Via The Motley Fool · May 1, 2025
Welding and cutting equipment manufacturer ESAB (NYSE:ESAB) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.7% year on year to $678.1 million. Its non-GAAP profit of $1.25 per share was 3.6% above analysts’ consensus estimates.
Via StockStory · May 1, 2025
Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% year on year to $108 million. The company’s full-year revenue guidance of $2 billion at the midpoint came in 6.1% below analysts’ estimates. Its GAAP loss of $2.52 per share was 18.6% above analysts’ consensus estimates.
Via StockStory · May 1, 2025
Engineered components manufacturer for critical industries ITT Inc. (NYSE: ITT) beat Wall Street’s revenue expectations in Q1 CY2025, but sales were flat year on year at $913 million. Its non-GAAP profit of $1.45 per share was 0.8% above analysts’ consensus estimates.
Via StockStory · May 1, 2025
Via The Motley Fool · May 1, 2025
Medical technology company Becton, Dickinson and Company (NYSE:BDX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 4.5% year on year to $5.27 billion. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $21.85 billion at the midpoint. Its non-GAAP profit of $3.35 per share was 2.1% above analysts’ consensus estimates.
Via StockStory · May 1, 2025
Gas handling company Chart (NYSE:GTLS) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 5.3% year on year to $1.00 billion. The company’s full-year revenue guidance of $4.75 billion at the midpoint came in 2.5% above analysts’ estimates. Its non-GAAP profit of $1.86 per share was 1.8% above analysts’ consensus estimates.
Via StockStory · May 1, 2025
Via The Motley Fool · May 1, 2025
A fundamental analysis of (NASDAQ:AAPL): Why APPLE INC (NASDAQ:AAPL) should be investigated by quality investors.
Via Chartmill · May 1, 2025
Gold prices extended their slide on Thursday, trading at around $3,220 per ounce during pre-market hours, as traders welcomed signs of progress in trade talks between the U.S. and countries facing President Trump's hefty tariff hikes.
Via Stocktwits · May 1, 2025